Claritas Pharmaceuticals Inc V.CLAS.H

Key take away from interview - GVHD handover clarification

[TheQQMon]

To be honest we will probably not take it forward.  We’re basically turning it back over to the Israeli group we bought it off of.   I know it’s a big disappointment to our shareholders as it is for us as the data showed that the product worked in the prevention of GVHD.  But, as you know, the reasons for this move were many - as you and I have spoken at length about it before.

(reasons were the cost of phase three which would require a larger pharma company taking the project over and, lacking the large market size they require as well as the CBD association made it a less than attractive opportunity for them.) 

[Jayjayt]

its time To sue kaly if that statment is true. We all ca me To kaly for gvhd. But now we have something To worrie about

[Jayjayt]

we have been screwed by kaly. If we vote no for the acquisition . So we have no compagny, no product. If my understandingis correct. .. Someone have To pay for our investment. Guys wake up. Th talent take it back. So de invested for them To be honest we will probably not take it forward. Were basically turning it back over to the Israeli group we bought it off of. I know its a big disappointment

[Jayjayt]

why not selling it. And we , shareholders can cet back our investment. The shitt Robert je saying is we gave it back. Wow. If de have no money sell it. Who decided that we Will give back the program??